ID   JFE-21
AC   CVCL_E6ME
RX   PubMed=39878900;
CC   Population: Japanese.
CC   Doubling time: 55.8 +- 7.0 h hours (PubMed=39878900).
CC   Karyotypic information: Near tetraploid karytotype (PubMed=39878900).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; B.cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=39878900
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 29,30
ST   D3S1358: 14,17
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 5,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39878900; DOI=10.1007/s13577-025-01176-0; PMCID=PMC11779770;
RA   Hoshino H., Akama T.O., Inoue D., Moritani S., Shigeto S., Matsuda K.,
RA   Yoshida H., Yonemoto N., Fukushima M., Yoshida Y., Kobayashi M.;
RT   "Establishment of a human ovarian endometrioid carcinoma cell line by
RT   constitutive expression of cyclin-dependent kinase 4, cyclin D1 and
RT   telomerase reverse transcriptase.";
RL   Hum. Cell 38:47.1-47.12(2025).
//